These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26623040)

  • 1. Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy.
    Nakamura K; Nishida T; Haruma T; Haraga J; Omichi C; Ogawa C; Kusumoto T; Seki N; Masuyama H; Hiramatsu Y
    Mol Clin Oncol; 2015 Sep; 3(5):1001-1006. PubMed ID: 26623040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer.
    Lee JW; Seol KH
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34069592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Haraga J; Nakamura K; Omichi C; Nishida T; Haruma T; Kusumoto T; Seki N; Masuyama H; Katayama N; Kanazawa S; Hiramatsu Y
    Mol Clin Oncol; 2016 Nov; 5(5):567-574. PubMed ID: 27900086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancer.
    Ida N; Nakamura K; Saijo M; Kusumoto T; Masuyama H
    Mol Clin Oncol; 2018 Feb; 8(2):257-263. PubMed ID: 29435286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
    Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy.
    Yun JM; Chung MK; Baek CH; Son YI; Ahn MJ; Oh D; Kim KW; So YK
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer.
    Prabawa IPY; Bhargah A; Liwang F; Tandio DA; Tandio AL; Lestari AAW; Budiana ING; Manuaba IBAP
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):863-868. PubMed ID: 30912405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2
    Hu Y; Wang S; Ding N; Li N; Huang J; Xiao Z
    Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
    Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
    Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio after First Cycle of Chemotherapy and Better Survival in Esophageal Cancer Patients Receiving Concurrent Chemoradiotherapy.
    Tseng RH; Lai KM; Tsai CY; Yan SL
    Curr Oncol; 2022 Nov; 29(11):8825-8834. PubMed ID: 36421347
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer.
    Liu D; Jin J; Zhang L; Li L; Song J; Li W
    Cell Physiol Biochem; 2018; 46(4):1595-1605. PubMed ID: 29694985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer.
    Nakamura K; Nagasaka T; Nishida T; Haruma T; Ogawa C; Kusumoto T; Seki N; Hiramatsu Y
    Oncol Lett; 2016 Jun; 11(6):3975-3981. PubMed ID: 27313726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors.
    He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL
    J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
    Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
    Wang C; Tong J; Tang M; Lu Y; Liang G; Zhang Z; Chen T
    Cancer Manag Res; 2021; 13():1075-1085. PubMed ID: 33574705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of hematological markers of systemic inflammation for managing cervical cancer.
    Wang L; Jia J; Lin L; Guo J; Ye X; Zheng X; Chen Y
    Oncotarget; 2017 Jul; 8(27):44824-44832. PubMed ID: 28148894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.